Filanesib (ARRY-520)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Filanesib (ARRY-520), covering 2020-09-16 to 2020-09-16. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma [Phase 2]